Fig. 3From: Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patientsRemission rate is depicted for iMN patients in two groups at two years. The line 1 means total remission rate in low-level group, the line 2 means total remission rate in high-level group, the line 3 means complete remission rate in low-level group, the line 4 means complete remission rate in high-level groupBack to article page